{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:50:03Z","timestamp":1793829003035,"version":"4.6.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejphar.2023.175521","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:45:00Z","timestamp":1674150300000},"page":"175521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease"],"prefix":"10.1016","volume":"942","author":[{"given":"Raysa S.","family":"Farias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo P.","family":"Silva-Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos P.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Acacia S.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo B.","family":"Peruchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-7753","authenticated-orcid":false,"given":"Celso","family":"Caruso-Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175521_bib1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib2","first-page":"384","article-title":"Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis","volume":"22","author":"Ashrafi Jigheh","year":"2019","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-020-2544-7","article-title":"Sodium-glucose cotransporter 2 inhibition suppresses HIF-1\u03b1-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice","volume":"11","author":"Cai","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175521_bib4","doi-asserted-by":"crossref","first-page":"18810","DOI":"10.1073\/pnas.0605029103","article-title":"PKB and megalin determine the survival or death of renal proximal tubule cells","volume":"103","author":"Caruso-Neves","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175521_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98720","article-title":"SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy","volume":"3","author":"Cassis","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2023.175521_bib6","doi-asserted-by":"crossref","first-page":"F988","DOI":"10.1152\/ajprenal.00295.2020","article-title":"Beyond the tubule: pathological variants of LRP2, encoding the megalin receptor, result in glomerular loss and early progressive chronic kidney disease","volume":"319","author":"Charlton","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2023.175521_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109506","article-title":"Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition","volume":"68","author":"Das","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2023.175521_bib8","first-page":"188","article-title":"Follow up of value of the intrarenal resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients, Open Access Maced","volume":"5","author":"Dayem","year":"2017","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11892-018-0992-6","article-title":"New diabetes therapies and diabetic kidney disease progression: the role of SGLT-2 inhibitors","volume":"18","author":"Dekkers","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.ejphar.2023.175521_bib11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s11255-020-02481-3","article-title":"A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin","volume":"52","author":"Eleftheriadis","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","volume":"308","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib13","article-title":"Urinary markers of tubular injury in early diabetic nephropathy","author":"Fishes","year":"2016","journal-title":"Internet J. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.64.1.129","article-title":"Renal tubular proteinuria and microalbuminuria in diabetic patients","volume":"64","author":"Gibb","year":"1989","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejphar.2023.175521_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/db16-0796","article-title":"Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease","volume":"66","author":"Gilbert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.175521_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000494390","article-title":"Mercapturate pathway in the tubulocentric perspective of diabetic kidney disease","volume":"143","author":"Gon\u00e7alves-Dias","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2023.175521_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrneph.2012.197","article-title":"Subclinical AKI--an emerging syndrome with important consequences","volume":"8","author":"Haase","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib18","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"DAPA-CKD Trial Committees and Investigators, Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175521_bib19","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1046\/j.1523-1755.2002.00634.x","article-title":"Expression profiling confirms the role of endocytic receptor megalin in renal vitamin D3 metabolism","volume":"62","author":"Hilpert","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2023.175521_bib20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41467-022-29124-8","article-title":"Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function","volume":"13","author":"Hinden","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.175521_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fendo.2019.00441","article-title":"Dapagliflozin attenuates renal tubulointerstitial fibrosis associated with type 1 diabetes by regulating STAT1\/TGF\u03b21 signaling","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.175521_bib22","article-title":"Recent advances in the emerging therapeutic strategies for diabetic kidney diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13098-019-0454-6","article-title":"Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice","volume":"11","author":"Inoue","year":"2019","journal-title":"Diabetol. Metab. Syndrome"},{"key":"10.1016\/j.ejphar.2023.175521_bib24","first-page":"5163","article-title":"Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K\/Akt\/GSK-3\u03b2 and Bax\/caspase-3 signaling pathways","volume":"14","author":"Jing","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2023.175521_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13340-020-00444-8","article-title":"Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches","volume":"11","author":"Kitada","year":"2020","journal-title":"Diabetol. Int."},{"key":"10.1016\/j.ejphar.2023.175521_bib26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4239\/wjd.v11.i12.596","article-title":"Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db\/db diabetic mice","volume":"11","author":"Klimontov","year":"2020","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2023.175521_bib27","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1038\/s41598-019-40163-y","article-title":"Mitochondria transfer from mesenchymal stem cells structurally and functionally repairs renal proximal tubular epithelial cells in diabetic nephropathy in vivo","volume":"9","author":"Konari","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175521_bib28","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3390\/ijms21082987","article-title":"SGLT2 inhibitor empagliflozin and DPP4 inhibitor linagliptin reactivate glomerular autophagy in db\/db mice, a model of type 2 diabetes","volume":"21","author":"Korbut","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1389557519666191009163519","article-title":"Recent developments in sodium-glucose co-transporter 2 (SGLT2) inhibitors as a valuable tool in the treatment of type 2 diabetes mellitus","volume":"20","author":"Kumar","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.175521_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107549","article-title":"5-Lypoxygenase products are involved in renal tubulointerstitial injury induced by albumin overload in proximal tubules in mice","volume":"9","author":"Landgraf","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175521_bib31","doi-asserted-by":"crossref","first-page":"F14","DOI":"10.1152\/ajprenal.00259.2021","article-title":"Cubilin-, megalin-, and Dab2-dependent transcription revealed by CRISPR\/Cas9 knockout in kidney proximal tubule cells","volume":"322","author":"Long","year":"2022","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2023.175521_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175521_bib33","article-title":"Reduced glomerular size selectivity in late streptozotocin-induced diabetes in rats: application of a distributed two-pore model","volume":"3","author":"Lubbad","year":"2015","journal-title":"Phys. Rep."},{"key":"10.1016\/j.ejphar.2023.175521_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175521_bib35","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1152\/physrev.00014.2021","article-title":"Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications","volume":"102","author":"Molitoris","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2023.175521_bib36","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/dc21-0076","article-title":"The effect of dapagliflozin on albuminuria in DECLARE-TIMI 58","volume":"44","author":"Mosenzon","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2023.175521_bib37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.ASN.0000057854.32413.81","article-title":"Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy","volume":"14","author":"Najafian","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib38","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc09-2242","article-title":"Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients","volume":"33","author":"Nielsen","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2023.175521_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2015.314","article-title":"Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes","volume":"89","author":"Nowak","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2023.175521_bib40","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203947","article-title":"High glucose-induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model","volume":"41","author":"Pan","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2023.175521_bib41","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1080\/13880209.2022.2116055","article-title":"Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt\/GSK-3\u03b2 signalling pathway","volume":"60","author":"Pei","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejphar.2023.175521_bib42","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"CREDENCE Trial Investigators, Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175521_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129950","article-title":"Megalin-mediated albumin endocytosis in renal proximal tubules is involved in the antiproteinuric effect of angiotensin II type 1 receptor blocker in a subclinical acute kidney injury animal model","volume":"1865","author":"Peruchetti","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejphar.2023.175521_bib44","doi-asserted-by":"crossref","first-page":"16790","DOI":"10.1074\/jbc.M114.549717","article-title":"Mis-regulation of mammalian target of rapamycin (mTOR) complexes induced by albuminuria in proximal tubules","volume":"289","author":"Peruchetti","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175521_bib45","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1074\/jbc.RA117.001337","article-title":"High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation","volume":"293","author":"Peruchetti","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175521_bib46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphys.2020.00172","article-title":"IL-4 receptor \u03b1 chain protects the kidney against tubule-interstitial injury induced by albumin overload","volume":"11","author":"Peruchetti","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2023.175521_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911203","article-title":"Changes in proximal tubular reabsorption modulate microvascular regulation via the TGF system","volume":"23","author":"Poursharif","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/IJNRD.S319933","article-title":"Role of urinary beta 2 microglobulin and kidney injury molecule-1 in predicting kidney function at one year following acute kidney injury","volume":"14","author":"Puthiyottil","year":"2021","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"10.1016\/j.ejphar.2023.175521_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1152\/ajprenal.00518.2013","article-title":"Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia","volume":"306","author":"Rieg","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2023.175521_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2008050503","article-title":"Impaired tubular uptake explains albuminuria in early diabetic nephropathy","volume":"20","author":"Russo","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib51","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2013070758","article-title":"Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes","volume":"25","author":"Sabbisetti","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib52","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1681\/ASN.2018050522","article-title":"Combined structural and functional imaging of the kidney reveals major axial differences in proximal tubule endocytosis","volume":"29","author":"Schuh","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/ijms23020848","article-title":"Albumin expands albumin reabsorption capacity in proximal tubule epithelial cells through a positive feedback loop between AKT and megalin","volume":"23","author":"Silva-Aguiar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175521_bib54","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/ndt\/gfs260","article-title":"The pathogenic role of the renal proximal tubular cell in diabetic nephropathy","volume":"27","author":"Tang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2023.175521_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215871","article-title":"Lithium ameliorates tubule-interstitial injury through activation of the mTORC2\/protein kinase B pathway","volume":"14","author":"Teixeira","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175521_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165907","article-title":"A high salt diet induces tubular damage associated with a pro-inflammatory and pro-fibrotic response in a hypertension-independent manner","volume":"1866","author":"Teixeira","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2023.175521_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100777","article-title":"Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db\/db mice","volume":"9","author":"Terami","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175521_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","article-title":"Rodent models of streptozotocin-induced diabetic nephropathy","volume":"12","author":"Tesch","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.ejphar.2023.175521_bib59","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1681\/ASN.2006111266","article-title":"Abrogation of protein uptake through megalin-deficient proximal tubules does not safeguard against tubulointerstitial injury","volume":"18","author":"Theilig","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s004180100317","article-title":"Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats","volume":"116","author":"Tojo","year":"2001","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175521_bib61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1291\/hypres.26.413","article-title":"Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats","volume":"26","author":"Tojo","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2023.175521_bib62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ki.2010.404","article-title":"Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-\u03b2-D-glucosaminidase","volume":"79","author":"Vaidya","year":"2011","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175521_bib63","doi-asserted-by":"crossref","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","article-title":"SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice","volume":"306","author":"Vallon","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2023.175521_bib64","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00424-020-02361-w","article-title":"Glucose transporters in the kidney in health and disease","volume":"472","author":"Vallon","year":"2020","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2023.175521_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1152\/ajprenal.00409.2012","article-title":"Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus","volume":"304","author":"Vallon","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2023.175521_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40620-018-00566-y","article-title":"Subclinical AKI: ready for primetime in clinical practice?","volume":"32","author":"Vanmassenhove","year":"2019","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13075-017-1317-x","article-title":"Ectopic germinal center and megalin defect in primary Sjogren syndrome with renal Fanconi syndrome","volume":"19","author":"Wang","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"12_Suppl. l","key":"10.1016\/j.ejphar.2023.175521_bib68","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1177\/09603271211051598","article-title":"Phillyrin ameliorates diabetic nephropathy through the PI3K\/Akt\/GSK-3\u03b2 signalling pathway in streptozotocin-induced diabetic mice","volume":"40","author":"Wang","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2023.175521_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8054073","article-title":"Improving the reliability and utility of streptozotocin-induced rat diabetic model","volume":"2018","author":"Wang-Fischer","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2023.175521_bib70","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"EMPA-REG OUTCOME Investigators, Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175521_bib71","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1093\/ndt\/gfn351","article-title":"Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy","volume":"23","author":"White","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2023.175521_bib72","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/cells10061457","article-title":"Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2023.175521_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247234","article-title":"Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells","volume":"16","author":"Zaibi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175521_bib74","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","article-title":"A more tubulocentric view of diabetic kidney disease","volume":"30","author":"Zeni","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175521_bib75","doi-asserted-by":"crossref","first-page":"24119","DOI":"10.18632\/oncotarget.15491","article-title":"High glucose induces apoptosis via upregulation of Bim expression in proximal tubule epithelial cells","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2023.175521_bib76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/DMSO.S289712","article-title":"Empagliflozin regulates the AdipoR1\/p-AMPK\/p-ACC pathway to alleviate lipid deposition in diabetic nephropathy","volume":"14","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.ejphar.2023.175521_bib77","first-page":"296","article-title":"Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy","volume":"66","author":"Ziqiang","year":"2016","journal-title":"J. Pakistan Med. Assoc."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:42:02Z","timestamp":1736329322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":77,"alternative-id":["S0014299923000328"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175521","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175521"}}